Effects of bariatric surgery and dietary intervention on insulin resistance and appetite hormones over a 3year period
Publication Details
Brzozowska, M. M.,
Isaacs, M.,
Bliuc, D.,
Baldock, P. A.,
Eisman, J. A.,
White, C. P.,
Greenfield, J. R.,
&
Center, J. R.
(2023).
Effects of bariatric surgery and dietary intervention on insulin resistance and appetite hormones over a 3year period.
Scientific Reports, 13 (4).
Abstract
To examine an impact of three types of bariatric surgery compared with dietary intervention (DIET), on concurrent changes in Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) and appetite hormones over 3 years. Fifty-fve adults were studied during phase of weight loss (0–12 months) and during weight stability (12–36 months) post intervention. Measurements of HOMA-IR, fasting and postprandial PYY and GLP1, adiponectin, CRP, RBP4, FGF21 hormones and dual-Xray absorptiometry were performed throughout the study. All surgical groups achieved signifcant reductions in HOMA-IR with greatest diference between Roux-en-Y gastric bypass and DIET (− 3.7; 95% CI − 5.4, − 2.1; p= 0.001) at 12–36 months. Initial (0–12 months) HOMA-IR values were no diferent to DIET after adjustment for the lost weight. During 12–36 months, after controlling for treatment procedure and weight, for every twofold increase in postprandial PYY and adiponectin, HOMA-IR decreased by 0.91 (95% CI − 1.71, − 0.11; p= 0.030) and by 0.59 (95% CI − 1.10, − 0.10; p= 0.023) respectively. Initial, non-sustained changes in RBP4 and FGF21 were not associated with HOMA-IR values. While initial rapid weight loss reduces insulin resistance, the enhanced secretions of PYY and adiponectin may contribute to weight-independent improvements in HOMA-IR during weight stability.
Clinical trial registration: Australian New Zealand Clinical Trials Registry (ANZCTR): ACTRN12613000188730.
Keywords
bariatric surgery, insulin resistance, homeostatic model assessment for insulin resistance, HOMA-IR
Link to Publisher Version (URL)
